{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T17:07:18Z","timestamp":1782580038701,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Foundation of the CAMS Initiative for Innovative Medicin","award":["(grant no. 2016-I2M-1-19)"],"award-info":[{"award-number":["(grant no. 2016-I2M-1-19)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12985-018-0963-1","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T04:11:48Z","timestamp":1522815108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3"],"prefix":"10.1186","volume":"15","author":[{"given":"Liming","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"963_CR1","doi-asserted-by":"crossref","unstructured":"Simmons CP, Farrar JJ, Nguyen V, Wills B. Dengue. New Engl J Med. 2012;366:1423\u201332.","DOI":"10.1056\/NEJMra1110265"},{"key":"963_CR2","doi-asserted-by":"crossref","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nat. 2013;496:504\u20137.","DOI":"10.1038\/nature12060"},{"key":"963_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1371\/journal.pntd.0000411","volume":"3","author":"L Eisen","year":"2009","unstructured":"Eisen L, Lozano-Fuentes S. Use of mapping and spatial and space-time modeling approaches in operational control of Aedes aegypti and dengue. PLos Neglect Trop D. 2009;3:411.","journal-title":"PLos Neglect Trop D"},{"key":"963_CR4","doi-asserted-by":"crossref","unstructured":"Zybert IA, et al. Immature dengue virus: a veiled pathogen. PLoS Pathog. 2010b;6(1000718).","DOI":"10.1371\/journal.ppat.1000718"},{"key":"963_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","volume":"60","author":"SB Halstead","year":"2013","unstructured":"Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res. 2013;60:421\u201367.","journal-title":"Adv Virus Res"},{"key":"963_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.146.1.201","volume":"146","author":"SB Halstead","year":"1977","unstructured":"Halstead SB, O\u2019Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977;146:201\u201317.","journal-title":"J Exp Med"},{"key":"963_CR7","first-page":"276","volume":"42","author":"SB Halstead","year":"1970","unstructured":"Halstead SB, Simasthien P. Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. Yale J Biol Med. 1970;42:276\u201392.","journal-title":"Yale J Biol Med"},{"key":"963_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","volume":"38","author":"SC Kliks","year":"1988","unstructured":"Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. AM J TROP MED HYG. 1988;38:411\u20139.","journal-title":"AM J TROP MED HYG"},{"key":"963_CR9","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1128\/JVI.00220-10","volume":"85","author":"K Boonnak","year":"2011","unstructured":"Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol. 2011;85:1671\u201383.","journal-title":"J Virol"},{"key":"963_CR10","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00018-010-0357-z","volume":"67","author":"IA Rodenhuis-Zybert","year":"2010","unstructured":"Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci. 2010a;67:2773\u201386.","journal-title":"Cell Mol Life Sci"},{"key":"963_CR11","doi-asserted-by":"crossref","unstructured":"Huang X, Yue Y, Li D, Zhao Y, Qiu L, Chen J, et al. Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated type-I IFN- independent signalling through upregulation of cellular autophagy. Sci Rep. 2016;6:22303.","DOI":"10.1038\/srep22303"},{"key":"963_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<329::AID-JMV12>3.0.CO;2-G","volume":"59","author":"S Green","year":"1999","unstructured":"Green S, et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol. 1999;59:329\u201334.","journal-title":"J Med Virol"},{"key":"963_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1099\/vir.0.82537-0","volume":"88","author":"T Chareonsirisuthigul","year":"2007","unstructured":"Chareonsirisuthigul T, Kalayanarooj S, Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. The Journal of general virology. 2007;88:365\u201375.","journal-title":"The Journal of general virology"},{"key":"963_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1423-0127-20-40","volume":"20","author":"TT Tsai","year":"2013","unstructured":"Tsai TT, et al. An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. J Biomed Sci. 2013;20:40.","journal-title":"J Biomed Sci"},{"key":"963_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15:509\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"963_CR16","doi-asserted-by":"crossref","unstructured":"DP. MicroRNA target recognition and regulatory functions. Cell. 2009;136:215\u201333.","DOI":"10.1016\/j.cell.2009.01.002"},{"key":"963_CR17","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1261\/rna.7135204","volume":"10","author":"X Cai","year":"2004","unstructured":"Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA. 2004;10:1957\u201366.","journal-title":"RNA"},{"key":"963_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.autrev.2009.01.008","volume":"8","author":"C Carissimi","year":"2009","unstructured":"Carissimi C, Fulci V, Macino G. MicroRNAs: novel regulators of immunity. Autoimmun Rev. 2009;8:520\u20134.","journal-title":"Autoimmun Rev"},{"key":"963_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fgene.2014.00178","volume":"5","author":"HM Lee","year":"2014","unstructured":"Lee HM, Nguyen DT, Lu LF. Progress and challenge of microRNA researchin immunity. Front Genet. 2014;5:178.","journal-title":"Front Genet"},{"key":"963_CR20","doi-asserted-by":"crossref","unstructured":"Powdrill MH, Desrochers GF, Singaravelu R, Pezacki JP. The role of microRNAs in metabolic interactions between viruses and their hosts. Curr Opin Virol. 2016;19:71\u20136.","DOI":"10.1016\/j.coviro.2016.07.005"},{"key":"963_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/rmv.1893","volume":"26","author":"N Sharma","year":"2016","unstructured":"Sharma N, Singh SK. Implications of non-coding RNAs in viral infections. Rev Med Virol. 2016;26:356\u201368.","journal-title":"Rev Med Virol"},{"key":"963_CR22","doi-asserted-by":"crossref","unstructured":"Chen RF, Yang KD. Augmented miR-150 expression associated with depressed SOCS1 expression involved in dengue haemorrhagic fever. J Infection. 69:366\u201374.","DOI":"10.1016\/j.jinf.2014.05.013"},{"key":"963_CR23","first-page":"34","volume":"9","author":"JH Malone","year":"2011","unstructured":"Malone JH, Oliver B. Microarrays, deep sequencing and the true measure of the transcriptome. BMCBiol. 2011;9:34.","journal-title":"BMCBiol"},{"key":"963_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","volume":"115","author":"BP Lewis","year":"2003","unstructured":"Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115:787\u201398.","journal-title":"Cell"},{"key":"963_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/nar\/gku1104","volume":"43","author":"N Wong","year":"2015","unstructured":"Wong N, Wang X. miRDB: an online resource for microRNA targetprediction and functional annotations. Nucleic Acids Res. 2015;43:146\u201352.","journal-title":"Nucleic Acids Res"},{"key":"963_CR26","unstructured":"Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubleaas tas sebour DJ, et al. Dengue: a continuing global threat. Microbiology. 2010;8:7\u201316."},{"key":"963_CR27","doi-asserted-by":"crossref","unstructured":"BD Gessner, Halsey N. incement, waning immunity, or chance occurrence?. Vaccine. 2017;35:3452\u20136.","DOI":"10.1016\/j.vaccine.2017.05.003"},{"key":"963_CR28","first-page":"2164","volume":"1","author":"J Torresi","year":"2017","unstructured":"Torresi J, Ebert G, Pellegrini M. Vaccines licensed and in clinical trials for theprevention of dengue. Hum Vaccin. 2017;1:2164.","journal-title":"Hum Vaccin"},{"key":"963_CR29","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1128\/JVI.02203-09","volume":"84","author":"Y Li","year":"2010","unstructured":"Li Y, Chan EY, Li J, Ni C, Peng X, Rosenzweig E, et al. MicroRNA expression and virulence in pandemic influnce zika virus-infected mice. J Virol. 2010;84:3023\u201332.","journal-title":"J Virol"},{"key":"963_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1182\/blood-2008-09-175000","volume":"113","author":"X Wang","year":"2009","unstructured":"Wang X, Ye L, Hou W, Zhou Y, Wang YJ, Metzger DS, et al. Cellular microRNA expression correlates with susceptibility of monocytes\/macrophages to HIV-1 infection. Blood. 2009;113:671\u20134.","journal-title":"Blood"},{"key":"963_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mc.20712","volume":"50","author":"J Xu","year":"2011","unstructured":"Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepato cellular carcinoma or chronic hepatitis. Mol Carcinog. 2011;50:136\u201342.","journal-title":"Mol Carcinog"},{"key":"963_CR32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3892\/mmr.2013.1288","volume":"7","author":"Y Qi","year":"2013","unstructured":"Qi Y, Li Y, Zhang L, Huang J. microRNA expression profiling and bioinformatic analysis of dengue virus infected peripheral blood mononuclear cells. Mol Med Rep. 2013;7:791\u20138.","journal-title":"Mol Med Rep"},{"key":"963_CR33","first-page":"68","volume":"5","author":"K Sidhu","year":"2015","unstructured":"Sidhu K, Kapoor NR, Pandey V, Kumar V. The macro world of microRNAs in hepatocellular carcinoma. Front. Oncologia. 2015;5:68.","journal-title":"Oncologia"},{"key":"963_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/B978-0-12-415795-8.00002-7","volume":"102","author":"AP Roberts","year":"2011","unstructured":"Roberts AP, Lewis AP, Jopling CL. The role of microRNAs in viral infection. Prog Mol Biol Transl Sci. 2011;102:101\u201339.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"963_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molcel.2005.09.012","volume":"20","author":"CS Sullivan","year":"2005","unstructured":"Sullivan CS, Ganem D. MicroRNAs and viral infection. Mol Cell. 2005;20:3\u20137.","journal-title":"Mol Cell"},{"key":"963_CR36","doi-asserted-by":"crossref","unstructured":"Na Wu., Na Gao., Dongying Fan., et al., 2014. miR-223 inhibits dengue virus replication by negatively regulating the microtubule-destabilizing protein STMN1 in EAhy926 cells. MICROBESINFECT 16, 911\u2013922.","DOI":"10.1016\/j.micinf.2014.08.011"},{"key":"963_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.semcancer.2008.01.005","volume":"18","author":"E Sonkoly","year":"2008","unstructured":"Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function an inflammation. Semin Cancer Biol. 2008;18:131\u201340.","journal-title":"Semin Cancer Biol"},{"key":"963_CR38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb0309-228","volume":"11","author":"J Winter","year":"2009","unstructured":"Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11:228\u201334.","journal-title":"Nat Cell Biol"},{"key":"963_CR39","first-page":"436097","volume":"1","author":"Z Gao","year":"2014","unstructured":"Gao Z, Dou Y, Chen Y, Zheng Y. MicroRNA roles in the NF-kappaB signaling pathway during viral infections. Biomed Res Int. 2014;1:436097.","journal-title":"Biomed Res Int"},{"key":"963_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jmcb\/mjr007","volume":"3","author":"X Ma","year":"2011","unstructured":"Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol. 2011;3:159\u201366.","journal-title":"J Mol Cell Biol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-0963-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-018-0963-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-0963-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T02:05:57Z","timestamp":1571018757000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-018-0963-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1186\/s12985-018-0963-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"17 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants were informed of the study aims, and written informed consent was received from each participant before sample collection.The study protocol was approved by the Institutional Ethics Committee (Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College) and was in accordance with the Declaration of Helsinki for Human Research of 1974 (last modified in 2000).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"50"}}